Skip to main content
SP5007,798.99+0.65%DOW53,839.99+0.13%NASDAQ26,803.03+0.81%BTC$63,483.00-0.06%ETH$1,886.42+0.31%GOLD$4,396.70-0.54%OIL$81.15-0.12%
Smart Investors Daily
Sign InSign Up Free
LF

NASDAQ · LFMDP

LifeMD, Inc.

Healthcare · Medical - Pharmaceuticals

$23.52

Up+$0.00 (+0.02%)

Updated Aug 14, 2026, 2:48 AM

SID Score

5.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
994.03M
P/E ratio
-34.8
Dividend yield
9.43%
52-week range
$22.34 – $24.20
Volume
2.36K
Avg. volume
1.64K

Price performance

LFMDP price history

1M range · 19 trading sessions · Daily adjusted prices

LFMDP closed at $23.52 after 19 trading sessions, up 0.94% for the selected period.

Last close
$23.52
Period change
+0.94%
Period low
$23.24
Period high
$23.55
Daily close
View OHLC price history
LFMDP OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 13, 2026$23.50$23.5199$23.49$23.51992.36K
Aug 12, 2026$23.50$23.515$23.48$23.5153.96K
Aug 11, 2026$23.5163$23.5163$23.48$23.504.18K
Aug 10, 2026$23.50$23.50$23.495$23.501.34K
Aug 7, 2026$23.41$23.46$23.41$23.46730.84
Aug 6, 2026$23.54$23.54$23.24$23.242.78K
Aug 5, 2026$23.49$23.50$23.48$23.502.24K
Aug 4, 2026$23.50$23.50$23.43$23.495.5K
Aug 3, 2026$23.46$23.46$23.46$23.462.14K
Jul 31, 2026$23.42$23.50$23.42$23.481.01K
Jul 30, 2026$23.3704$23.43$23.3704$23.43895.84
Jul 29, 2026$23.49$23.50$23.35$23.501.65K
Jul 28, 2026$23.3588$23.50$23.3588$23.45941.93K
Jul 27, 2026$23.3297$23.3297$23.3297$23.3297340.84
Jul 24, 2026$23.5467$23.5467$23.5467$23.5467317.84
Jul 23, 2026$23.3605$23.43$23.36$23.361.3K
Jul 20, 2026$23.3484$23.3484$23.3484$23.3484726.84
Jul 17, 2026$23.40$23.40$23.325$23.325414.84
Jul 16, 2026$23.3016$23.302$23.3016$23.302449.84

Latest LFMDP news

The latest Smart Investors Daily articles mentioning LFMDP.

Stock researchCompany · Overview

LFMDP research

Overview

Company profile and research snapshot.

Company profile

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$57.55
Implied upside
—
Analysts
14
LFMDP recent ratings
DateFirmRatingTarget
Aug 7, 2026HC Wainwright & Co.Buy—
Aug 6, 2026B. Riley SecuritiesBuy—
Aug 6, 2026BTIGBuy—
May 26, 2026HC Wainwright & Co.Buy—
May 4, 2026BTIGBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 23, 2026

How The New LifeMD (LFMD) Price Target Is Shaping The Investment Story

What the New LifeMD Price Target Tells You Analysts have updated their price target for LifeMD, marking a key shift in how the stock is being framed and discussed. This change reflects a refreshed view of the company that pulls together recent business developments and expectations already circulating in the market. Stay tuned to see how you can keep on top of future price target moves and the evolving narrative around LifeMD from here. Analyst Price Targets don't always capture the full...

Yahoo · Jan 14, 2026

BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS)

Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Beauty Stocks to Buy Right Now. TheFly reported on January 8, 2026, that BofA reduced the price target for Hims & Hers Health, Inc. (NYSE:HIMS) to $29 from $32. It retained an Underperform rating on the stock. The firm claims that the consensus expectations […]

defenseworld.net · Dec 12, 2025

LifeMD (NASDAQ:LFMDP) Trading 0.5% Higher – Time to Buy?

LifeMD, Inc. (NASDAQ: LFMDP - Get Free Report)'s share price traded up 0.5% on Thursday. The company traded as high as $22.63 and last traded at $22.75. 656 shares changed hands during mid-day trading, a decline of 81% from the average session volume of 3,477 shares. The stock had previously closed at $22.63. LifeMD Stock

seekingalpha.com · Nov 17, 2025

LifeMD, Inc. (LFMD) Q3 2025 Earnings Call Transcript

LifeMD, Inc. ( LFMD ) Q3 2025 Earnings Call November 17, 2025 4:30 PM EST Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG, LLC, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Anderson Schock - B. Riley Securities, Inc., Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Eduardo Martinez-Montes - H.C.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By